Correlation Between Day One and Rezolute
Can any of the company-specific risk be diversified away by investing in both Day One and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Rezolute, you can compare the effects of market volatilities on Day One and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Rezolute.
Diversification Opportunities for Day One and Rezolute
Very weak diversification
The 3 months correlation between Day and Rezolute is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Day One i.e., Day One and Rezolute go up and down completely randomly.
Pair Corralation between Day One and Rezolute
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.79 times more return on investment than Rezolute. However, Day One Biopharmaceuticals is 1.26 times less risky than Rezolute. It trades about -0.27 of its potential returns per unit of risk. Rezolute is currently generating about -0.27 per unit of risk. If you would invest 1,485 in Day One Biopharmaceuticals on September 14, 2024 and sell it today you would lose (204.00) from holding Day One Biopharmaceuticals or give up 13.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Day One Biopharmaceuticals vs. Rezolute
Performance |
Timeline |
Day One Biopharmaceu |
Rezolute |
Day One and Rezolute Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Day One and Rezolute
The main advantage of trading using opposite Day One and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
Rezolute vs. Puma Biotechnology | Rezolute vs. Iovance Biotherapeutics | Rezolute vs. Day One Biopharmaceuticals | Rezolute vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |